Our Team：

Our new drug research and development team enjoys a very reputation in the industry. Our core technical personnel are all experts in bioengineering, immunology, pathology, pharmacy and other biomedical related fields and have many years’ experience in new drug research and development, manufacturing and quality management. In order to strengthen our research and development capabilities, we also invite industry's leading scientists to be our researchers and technical advisers.

Facilities and Equipment：

Our company has over 2000 square meters’ laboratory space and necessary equipment for conducting cutting-edge research and development and testing. Our multi-functional laboratories are equipped with advanced equipment such as the world's most advanced 3D small animal live imaging CT machine, high-performance liquid chromatograph etc.

Research and Development Services：

1. BrightShines’ focus is drug toxicology and tumor pharmacology research. In addition, we also actively engage in R&D of other medicine such as anti-radiation drugs, hematopoietic drugs, cardiovascular drugs, hepatoprotectants, anti-osteoporosis drugs, and fracture healing drugs. Our drug assessment services are in line with the developments in drug toxicology and the requirements of China Food and Drug Administration (CFDA).

2、BrightShines is committed to fundamental theoretical research in new drug research and development. Diseases such as radiation damage, cancer, cardio-cerebrovascular diseases need multi-target combinational drugs, which require quantitative analysis of interaction among different factors. Our research team has completed the theoretical derivation of calculating the interactions and additive effects of the combinational drugs.

We have filed the China patent application for core content of the key publication - “Establishment of new method for quantitatively calculating synergistic, additive and antagonistic effect in multiple-drug combination”. International patent application is undergoing, and the multi-target combinational drug calculation platform has been established.

Service Mission：

We follow the principle of "Serve medicine innovations, benefit human society". We strive to provide seamless one-stop services to our clients in pre-clinical new drug trials and new drug registration.